Eligible participants had jejunal placement of a percutaneous gastrojejunostomy tube , and were then randomly allocated ( 1:1 ) to treatment with immediate-release oral levodopa-carbidopa plus placebo intestinal gel infusion or levodopa-carbidopa intestinal gel infusion plus oral placebo .